Skip to main content
. 2019 Jun 7;9:480. doi: 10.3389/fonc.2019.00480

Table 1.

Breast cancer subtypes show differences in the expression level of mitochondria-related genes.

Normal-like Luminal A Luminal B HER2-enriched Basal-like
Gene Mean ± SD ANOVA Mean ± SD ANOVA Mean ± SD ANOVA Mean ± SD ANOVA Mean ± SD ANOVA
Fusion OPA1 −0.25 ± 0.9 −0.244 ± 0.96 0.34 ± 1.3 1 0.978 ± 1.3 0,1,2 1.303 ± 1.5 0,1,2
MFN1 −0.74 ± 1.18 −0.015, 1.15 0.516 ± 1.2 1 0.617 ± 1.4 0,1 1.117 ± 1.5 0,1,2
MFN2 −0.17 ± 0.82 −0.124 ± 1.08 −0.54 ± 1.3 1 −0.57 ± 1.4 −0.56 ± 1.4
Fission DNM1L −0.62 ± 1.04 −0.302 ± 1.03 0.276 ± 1.1 1 0.293 ± 1.2 1 1.023 ± 1.5 0,1,2,3
MTP18/MTFP1 −0.28 ± 0.86 −0.585 ± 1.05 −0.01 ± 1.1 1 0.201 ± 1 1 0.235 ± 1.1 1
YME1L1 −0.79 ± 1.77 −0.204 ± 1.1 0.378 ± 1.1 1 0.2 ± 1.4 0.843 ± 1.9 0,1
MID51/MIEF1 −0.38 ± 0.75 −0.681 ± 1.05 −0.56 ± 1.3 0.297 ± 1.4 1,2 0.629 ± 1.2 1,2
MARCH5 −1.47 ± 1.25 −0.14 ± 0.87 0 −0.09 ± 1.1 0 0.142 ± 1.3 0 −0.43 ± 1.3 3
MFF −0.29 ± 1.26 −0.119 ± 1.01 −0.23 ± 1 −0.17 ± 1.2 0.071 ± 1.3
FIS1 −0.61 ± 1.13 0.25 ± 0.97 0.151 ± 1.1 −0.44 ± 1 1,2 −0.82 ± 1 1,2
OMA1 −0.29 ± 0.87 0.241 ± 0.95 0.115 ± 1.1 −0.66 ± 1.3 1,2 −0.56 ± 1 1,2
MID49/MIEF2 −0.49 ± 0.79 0.11 ± 0.95 −0.28 ± 1.1 −0.39 ± 0.8 1,2 −1.24 ± 1 1,2,3
Mitophagy BNIP3L −0.5 ± 1.09 −0.084 ± 1.06 −0.76 ± 1.1 1 −0.75 ± 1.2 1 −1.33 ± 1.1 1, 2, 3
PINK1 0.153 ± 0.93 0.146 ± 0.92 −0.44 ± 1 1 −0.51 ± 1 1 −0.84 ± 1.1 1
PARK2 −0.5 ± 1.09 −0.084 ± 1.06 −0.76 ± 1.1 1 −0.75 ± 1.2 1 −1.33 ± 1.1
Biogenesis PPARGC1A 0.388 ± 0.39 −0.066 ± 0.7 −0.51 ± 0.7 1 0.278 ± 1 2 0.961 ± 1.6 1,2,3
PPARGC1B 0.395 ± 0.87 −0.285 ± 0.84 −0.16 ± 1 0.531 ± 1 1,2 1.001 ± 0.9 1,2,3
Other SIRT3 −1.04 ± 0.7 0.382 ± 0.93 0 −0.06 ± 1.1 0, 1 −0.82 ± 0.9 1,2 −1.4 ± 0.9 1,2,3

mRNA expression z-scores (microarray) analyses from TGCA samples according to their breast cancer sybtype (PAM50 classification). Gray cell means differences with p < 0.05 to Normal-like (0), Luminal A (1), Luminal B (2), or HER2 (3).